H.Amdt.712 - An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.
About This Bill
Passed
Latest Action · December 12, 2019
On agreeing to the Tonko amendment (A002) Agreed to by voice vote.